Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study
Authors:
- 7 June 2026
- journal article
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 14 (8) , 649-661
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 26 references indexed in Scilit:
- 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050The Lancet Diabetes & Endocrinology, 2025
- Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialThe Lancet, 2023
- Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversationThe Lancet, 2022
- Primary and Secondary Outcome Reporting in Randomized TrialsJACC, 2021
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trialThe Lancet, 2021
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trialThe Lancet, 2021
- Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trialDiabetologia, 2017
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trialThe Lancet Diabetes & Endocrinology, 2017
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric testsBiometrical Journal, 2011